×

Molecular biomarker set for early detection of ovarian cancer

  • US 9,057,107 B2
  • Filed: 03/08/2012
  • Issued: 06/16/2015
  • Est. Priority Date: 03/08/2011
  • Status: Active Grant
First Claim
Patent Images

1. A method of identifying ovarian cancer in an individual or the risk of developing ovarian cancer in an individual, consisting of the steps:

  • a) obtaining nucleic acids from a sample from the individual suspected of having ovarian cancer;

    b) detecting the expression level of TFAP2A from the sample from the individual with the expression level of TFAP2A from a control, andc) detecting the expression level of CA125 and E2F5 from the sample from the individual with the expression level of CA125 and E2F5 from a control.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×